Lazard US Mid Cap Equity Portfolio Institutional Shares (LZMIX)

20.18
Net Asset Value
-1.32%
1 Day
+6.94%
Year-to-Date
Overall Morningstar Rating
Mid-cap blend
Style or Category
No Load
Sales Expenses
1.19%
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The Portfolio invests primarily in a focused portfolio of equity securities, principally common stocks, of mid cap U.S. companies that the Investment Manager believes have strong and/or improving financial productivity and are undervalued based on their earnings, cash flow or asset values. It invests at least 80% of its assets in equity securities of medium-size (mid cap) U.S. companies. The Portfolio may invest up to 20% of its assets in equity securities of larger or smaller U.S. or non-U.S. companies. It is non-diversified.

Performance

1 month+0.49% 3 years+17.53%
3 months+7.92% 5 years+12.32%
1 year+23.55% Since inception+8.88%
Data through --

Peer Comparisonvs. Mid-cap blend

 LZMIXCategory
Performance 5-yr return+12.32%+13.75%
Expense ratio1.19%1.22%
Risk 5 year sharpe ratio0.920.92
Net assets$39.0M$1.8B
Average market cap$8.1B$7.6B
Average P/E16.520.6
Portfolio turnover95%95%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyLazard
Fund manager & tenureAndrew Lacey / 14 Years
Minimal initial investment$100,000.00
Minimum IRA investment$100,000.00

Holdings

U.S. stock83.74%
International stock8.52%
Cash7.75%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Industrial materials 17.97%
Financial service 17.57%
Consumer goods 14.03%
Energy 12.88%
Consumer service 9.16%
Top 10 Holdings
Portfolio weighting
KSS Kohls Corp6.10%
VOYA Voya Financial Inc6.03%
AAP Advance Auto Parts Inc5.61%
MDCA MDC Partners Inc5.14%
DKS Dick's Sporting Goods Inc4.75%
ICE Intercontinental Exchange Inc4.72%
K Kellogg4.69%
CTXS Citrix Systems Inc4.34%
TAP Molson Coors Brewing Co4.05%
UTHR United Therapeutics Corp3.92%

To view my watchlist

Not a member yet?

Sign up now for a free account